Document Detail


Targeting of antisense PNA oligomers to human galanin receptor type 1 mRNA.
MedLine Citation:
PMID:  15464198     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In this work, we have targeted positions 18-38 of the human galanin receptor type 1 (GalR1) mRNA coding sequence with different peptide nucleic acid (PNA) oligomers. This region has previously been shown to be a good antisense region and therefore we aimed to identify the subregions and/or thermodynamic parameters determining the antisense efficacy. Nine different PNA oligomers were conjugated to a cell-penetrating peptide, transportan, to enhance their cellular uptake. Concentration-dependent down-regulation of GalR1 protein expression in human melanoma cell line Bowes was measured by radioligand binding assay. No reduction of GalR1 mRNA level was observed upon PNA treatment, thus, the effect was concluded to be translational arrest. Judging from the EC50 values, antisense PNA oligomers targeting regions 24-38 (EC50=70 nM) or 27-38 (EC50=80 nM) were the most potent suppressors of protein expression. No parameter predicted by M-fold algorithm was found to correlate with the measured antisense activities. Presence of some subregions was found not to increase antisense efficiency of PNA. Presence of a short unpaired triplet between nucleotides 33 and 35 in the target region was, on the other hand, found to be the most critical for efficient GalR1 down-regulation. Thus, the results are of high impact in designing antisense oligomers. Specific results of this study demonstrate 20-fold more efficient antisense down-regulation of GalR1 as achieved before.
Authors:
Kalle Kilk; Anna Elmquist; Külliki Saar; Margus Pooga; Tiit Land; Tamas Bartfai; Ursel Soomets; Ulo Langel
Related Documents :
12441288 - Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cere...
8289968 - Multiple fractions of gamma rays do not induce overexpression of c-myc or c-ki-ras onco...
20081848 - Regulation of hematopoietic stem cell differentiation by a single ubiquitin ligase-subs...
10581008 - Polyamine depletion up-regulates c-myc expression, yet induces g(1) arrest and terminal...
20043878 - Identification of a new secretory factor, ccdc3/favine, in adipocytes and endothelial c...
9315658 - In vivo regulation of alternative pre-mrna splicing by the clk1 protein kinase.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuropeptides     Volume:  38     ISSN:  0143-4179     ISO Abbreviation:  Neuropeptides     Publication Date:  2004 Oct 
Date Detail:
Created Date:  2004-10-06     Completed Date:  2005-03-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8103156     Medline TA:  Neuropeptides     Country:  Scotland    
Other Details:
Languages:  eng     Pagination:  316-24     Citation Subset:  IM    
Affiliation:
Department of Neurochemistry and Neurotoxicology, Arrhenius Laboratories, Stockholm University, Svante Arrheniusvag. 21A, S-10691 Stockholm, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Line, Tumor
Down-Regulation
Humans
Nucleic Acid Conformation
Oligonucleotides, Antisense / genetics,  metabolism*
Peptide Nucleic Acids / genetics,  metabolism*
RNA, Messenger / chemistry,  genetics,  metabolism*
Receptor, Galanin, Type 1 / genetics*,  metabolism
Chemical
Reg. No./Substance:
0/Oligonucleotides, Antisense; 0/Peptide Nucleic Acids; 0/RNA, Messenger; 0/Receptor, Galanin, Type 1

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depressio...
Next Document:  Plasma levels of alpha-melanotropin and ACTH-like immunoreactivities do not vary by season or skin t...